Pigment Epithelium-Derived Factor Gene Met72Thr Polymorphism Is Associated With Increased Risk of Wet Age-related Macular Degeneration

American Journal of Ophthalmology

Volumn 145, Issue 4, 2008, Pages

  Lin, Jane Ming ^a   Wan, Lei ^a,c   Tsai, Yi Yu ^a   Lin, Hui Ju ^a   Tsai, Yushin ^b   Lee, Cheng Chun ^a   Tsai, Chang Hai ^a,c   Tseng, Sung Huei ^d   Tsai, Fuu Jen ^a,b,c  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c ASIA UNIVERSITY   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

PIGMENT EPITHELIUM DERIVED FACTOR;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ATROPHY; BODY MASS; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CHINESE; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RETINA NEOVASCULARIZATION; RISK FACTOR;

EID: 40849135678     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2007.11.006     Document Type: Article

References (51)

1. Bird A.C. The Bowman lecture: towards an understanding of age-related macular disease. Eye 17 (2003) 457-466
2. Congdon N., O'Colmain B.J., Klaver C.C., et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 122 (2004) 477-485
3. Friedman D.S., O'Colmain B.J., Munoz B., et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 122 (2004) 564-572
4. Klein R.J., Zeiss C., Chew E.Y., et al. Complement factor H polymorphism in age-related macular degeneration. Science 308 (2005) 385-389
5. Sepp T., Khan J.C., Thurlby D.A., et al. Complement factor H variant Y402H is a major risk determinant for geographic atrophy and choroidal neovascularization in smokers and nonsmokers. Invest Ophthalmol Vis Sci 47 (2006) 536-540
6. Lau L.I., Chen S.J., Cheng C.Y., et al. Association of the Y402H polymorphism in complement factor H gene and neovascular age-related macular degeneration in Chinese patients. Invest Ophthalmol Vis Sci 47 (2006) 3242-3246
7. Narayanan R., Butani V., Boyer D.S., et al. Complement factor H polymorphism in age-related macular degeneration. Ophthalmology 114 (2007) 1327-1331
8. DeWan A., Liu M., Hartman S., et al. HTRA1 promoter polymorphism in wet age-related macular degeneration. Science 314 (2006) 989-992
9. Yang Z., Camp N.J., Sun H., et al. A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science 314 (2006) 992-993
10. Yoshida T., DeWan A., Zhang H., et al. HTRA1 promoter polymorphism predisposes Japanese to age-related macular degeneration. Mol Vis 13 (2007) 545-548
11. Zhang S.X., and Ma J.X. Ocular neovascularization: Implication of endogenous angiogenic inhibitors and potential therapy. Prog Retin Eye Res 26 (2007) 1-37
12. Holekamp N.M., Bouck N., and Volpert O. Pigment epithelium-derived factor is deficient in the vitreous of patients with choroidal neovascularization due to age-related macular degeneration. Am J Ophthalmol 134 (2002) 220-227
13. Bhutto I.A., McLeod D.S., Hasegawa T., et al. Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration. Exp Eye Res 82 (2006) 99-110
14. Zhang S.X., Wang J.J., Gao G., Shao C., Mott R., and Ma J.X. Pigment epithelium-derived factor (PEDF) is an endogenous antiinflammatory factor. FASEB J 20 (2006) 323-325
15. Stellmach V., Crawford S.E., Zhou W., and Bouck N. Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor. Proc Natl Acad Sci U S A 98 (2001) 2593-2597
16. Saishin Y., Silva R.L., Saishin Y., et al. Periocular gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization in a human-sized eye. Hum Gene Ther 16 (2005) 473-478
17. Mori K., Duh E., Gehlbach P., et al. Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization. J Cell Physiol 188 (2001) 253-263
18. Mori K., Gehlbach P., Ando A., et al. Regression of ocular neovascularization in response to increased expression of pigment epithelium-derived factor. Invest Ophthalmol Vis Sci 43 (2002) 2428-2434
19. Mori K., Gehlbach P., Yamamoto S., et al. AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization. Invest Ophthalmol Vis Sci 43 (2002) 1994-2000
20. Liu H., Ren J.G., Cooper W.L., Hawkins C.E., Cowan M.R., and Tong P.Y. Identification of the antivasopermeability effect of pigment epithelium-derived factor and its active site. Proc Natl Acad Sci U S A 101 (2004) 6605-6610
21. Campochiaro P.A., Nguyen Q.D., Shah S.M., et al. Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: results of a phase I clinical trial. Hum Gene Ther 17 (2006) 167-176
22. Koenekoop R., Pina A.L., Loyer M., et al. Four polymorphic variations in the PEDF gene identified during the mutation screening of patients with Leber congenital amaurosis. Mol Vis 5 (1999) 10
23. Yamagishi S., Amano S., Inagaki Y., et al. Pigment epithelium-derived factor Met72Thr polymorphism in patients with diabetic microangiopathy. Int J Clin Pharmacol Res 22 (2002) 67-71
24. Yamagishi S., Nakamura K., Inoue H., and Takeuchi M. Met72Thr polymorphism of pigment epithelium-derived factor gene and susceptibility to age-related macular degeneration. Med Hypotheses 64 (2005) 1202-1204
25. Bird A.C., Bressler N.M., Bressler S.B., et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The international ARM Epidemiological Study Group. Surv Ophthalmol 39 (1995) 367-374
26. Tatar O., Kaiserling E., Adam A., et al. Consequences of verteporfin photodynamic therapy on choroidal neovascular membranes. Arch Ophthalmol 124 (2006) 815-823 2
27. Lopez P.F., Sippy B.D., Lambert H.M., Thach A.B., and Hinton D.R. Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. Invest Ophthalmol Vis Sci 37 (1996) 855-868
28. Kvanta A., Algvere P.V., Berglin L., and Seregard S. Subfoveal fibrovascular membranes in age-related macular degeneration expresses vascular endothelial growth factor. Invest Ophthalmol Vis Sci 37 (1996) 1929-1934
29. Amin R., Puklin J.E., and Frank R.N. Growth factor localization in choroidal neovascular membranes of age-related macular degeneration. Invest Ophthalmol Vis Sci 35 (1994) 3178-3188
30. Lip P.L., Blann A.D., Hope-Ross M., Gibson J.M., and Lip G.Y. Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunction. Ophthalmology 108 (2001) 705-710
31. Wells J.A., Murthy R., Chibber R., et al. Levels of vascular endothelial growth factor are elevated in the vitreous of patients with subretinal neovascularization. Br J Ophthalmol 80 (1996) 363-366
32. Kliffen M., Sharma H.S., Mooy C.M., Kerkvliet S., and de Jong P.T. Increased expression of angiogenic growth factors in age-related maculopathy. Br J Ophthalmol 81 (1997) 154-162
33. Tombran-Tink J., Shivaram S.M., Chader G.J., Johnson L.V., and Bok D. Expression, secretion, and age-related downregulation of pigment epithelium-derived factor, a serpin with neurotrophic activity. J Neurosci 15 (1995) 4992-5003
34. Renno R.Z., Youssri A.I., Michaud N., Gragoudas E.S., and Miller J.W. Expression of pigment epithelium-derived factor in experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 43 (2002) 1574-1580
35. Martin G., Schlunck G., Hansen L.L., and Agostini H.T. Differential expression of angioregulatory factors in normal and CNV-derived human retinal pigment epithelium. Graefes Arch Clin Exp Ophthalmol 242 (2004) 321-326
36. Tombran-Tink J., and Johnson L.V. Neuronal differentiation of retinoblastoma cells induced by medium conditioned by human RPE cells. Invest Ophthalmol Vis Sci 30 (1989) 1700-1707
37. Tombran-Tink J., and Barnstable C.J. PEDF: a multifaceted neurotrophic factor. Nat Rev Neurosci 4 (2003) 628-636
38. Becerra S.P., Sagasti A., Spinella P., and Notario V. Pigment epithelium-derived factor behaves like a noninhibitory serpin. Neurotrophic activity does not require the serpin reactive loop. J Biol Chem 270 (1995) 25992-25999
39. Becerra S.P. Structure-function studies on PEDF. A noninhibitory serpin with neurotrophic activity. Adv Exp Med Biol 425 (1997) 223-237
40. Araki T., Taniwaki T., Becerra S.P., Chader G.J., and Schwartz J.P. Pigment epithelium-derived factor (PEDF) differentially protects immature but not mature cerebellar granule cells against apoptotic cell death. J Neurosci Res 53 (1998) 7-15
41. Dawson D.W., Volpert O.V., Gillis P., et al. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 285 (1999) 245-248
42. Gao G., Li Y., Zhang D., Gee S., Crosson C., and Ma J. Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization. FEBS Lett 489 (2001) 270-276
43. Volpert O.V., Zaichuk T., Zhou W., et al. Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor. Nat Med 8 (2002) 349-357
44. de Jong P.T. Age-related macular degeneration. N Engl J Med 355 (2006) 1474-1485
45. Postel E.A., Agarwal A., Caldwell J., et al. Complement factor H increases risk for atrophic age-related macular degeneration. Ophthalmology 113 (2006) 1504-1507
46. Cahill M.T., Mruthyunjaya P., Bowes-Rickman C., and Toth C.A. Recurrence of retinal pigment epithelial changes after macular translocation with 360 degrees peripheral retinectomy for geographic atrophy. Arch Ophthalmol 123 (2005) 935-938
47. Dunaief J.L., Dentchev T., Ying G.S., and Milam A.H. The role of apoptosis in age-related macular degeneration. Arch Ophthalmol 120 (2002) 1435-1442
48. Kondo N., Honda S., Ishibashi K., Tsukahara Y., and Negi A. LOC387715/HTRA1 variants in polypoidal choroidal vasculopathy and age-related macular degeneration in a Japanese population. Am J Ophthalmol 144 (2007) 608-612
49. Kanda A., Chen W., Othman M., et al. A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration. Proc Natl Acad Sci U S A 104 (2007) 16227-16232
50. Cai J., Nelson K.C., Wu M., Sternberg Jr. P., and Jones D.P. Oxidative damage and protection of the RPE. Prog Retin Eye Res 19 (2000) 205-221
51. Ohno-Matsui K., Morita I., Tombran-Tink J., et al. Novel mechanism for age-related macular degeneration: an equilibrium shift between the angiogenesis factors VEGF and PEDF. J Cell Physiol 189 (2001) 323-333